Cargando…
Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746418/ https://www.ncbi.nlm.nih.gov/pubmed/29300397 http://dx.doi.org/10.18632/oncotarget.23291 |
| _version_ | 1783289102826733568 |
|---|---|
| author | Zhang, Nasha Kong, Li Shi, Fang Jing, Wang Wang, Haiyong Yang, Ming Yu, Jinming Zhu, Hui |
| author_facet | Zhang, Nasha Kong, Li Shi, Fang Jing, Wang Wang, Haiyong Yang, Ming Yu, Jinming Zhu, Hui |
| author_sort | Zhang, Nasha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5746418 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57464182018-01-03 Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed Zhang, Nasha Kong, Li Shi, Fang Jing, Wang Wang, Haiyong Yang, Ming Yu, Jinming Zhu, Hui Oncotarget Correction Impact Journals LLC 2017-12-15 /pmc/articles/PMC5746418/ /pubmed/29300397 http://dx.doi.org/10.18632/oncotarget.23291 Text en Copyright: © 2017 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Correction Zhang, Nasha Kong, Li Shi, Fang Jing, Wang Wang, Haiyong Yang, Ming Yu, Jinming Zhu, Hui Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| title | Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| title_full | Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| title_fullStr | Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| title_full_unstemmed | Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| title_short | Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| title_sort | correction: kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746418/ https://www.ncbi.nlm.nih.gov/pubmed/29300397 http://dx.doi.org/10.18632/oncotarget.23291 |
| work_keys_str_mv | AT zhangnasha correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT kongli correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT shifang correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT jingwang correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT wanghaiyong correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT yangming correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT yujinming correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed AT zhuhui correctionkineticchangeofserumcarcinoembryonicantigencanearlypredictprogressioninpatientswithmetastaticnonsmallcelllungcancerduringmaintenancetherapywithbevacizumabpluspemetrexed |